The Polaris Dawn mission is scheduled to launch in the coming months and pre-flight and post-flight data collection will be supported by TrialX. The crew of this planned private human spaceflight mission will spend five days in orbit and our team is working tirelessly to ensure that the four crew members are able to collect all health research data seamlessly using the EXPAND Polaris Dawn App. Space researchers are now able to reuse and integrate research data across different research studies and unlock innovative actionable insights within the TrialX database. Learn more.
What’s new at TrialX?
š¢ PRODUCT UPDATES
Proud of our team! We delivered a successful demo to NASA and Translational Research Institute for Space Health (TRISH) recently! We’re breaking new ground in remote research data collection, storage and dissemination – not only on earth, but also in space. In partnership with TRISH, our innovation aims to ensure prompt medical care for spaceflight participants (SFPs) in case of emergencies, byĀ enablingĀ them to collect health data offline and easily share it with crew in various space environments. TrialX was selected by TRISH to be a part of a pioneering collaboration to develop systems to improve healthcare delivery and data management for spaceflight participants and researchers. Such projects hold the potential to reshape the future of space health as well as transform healthcare on earth, and we couldn’t be more thrilled to contribute to this mission!Ā Read more.
š§āš»ļø UPCOMING CONFERENCES
Our CSO, Paul Donnelly, is gearing up to attend the second Digital Biomarker Summit USA and dive deep into the latest trends and innovations in digital health technology and digital biomarkers. From discussing the collaboration in digital measurement to exploring the role of wearables in AI, this one-day event promises to be an enlightening journey into the future of healthcare. Stay tuned for updates as we explore the cutting-edge advancements shaping the industry!
RECENT CURETALKS 
Women with inactivating mutations in BRCA genes face elevated lifetime risks of recurrent breast and ovarian cancers, often having to undergo vigilant monitoring with some having to opt for preventive surgeries to remove their breasts and ovaries to reduce cancer risks. Despite advancements in understanding the initial cancer development, the factors driving recurrence of these BRCA related cancers remain elusive. In our recent CureTalks episode watch Dr. Katherine L. Nathanson of the University of Pennsylvania discuss the complexities of BRCA related breast & ovarian cancers and share insights into ongoing research and the potential avenues for future breakthroughs. Watch here.
š§¬ FEATURED CLINICAL STUDIES
Powered by TrialX
Volunteers Needed for Obstructive Sleep Apnea, Pain and Physical Activity Study: This study is comparing the effects of brief bouts of physical activity on bodily pain thresholds in persons with and without obstructive sleep apnea. Overweight adults (BMI > 25) between the ages of 18 to 65 years can participate. Learn more.
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM: This research aims to conduct a community intervention study that will 1) validate a screening approach to identify patients at risk for advanced NAFLD in the obese or T2DM population, and 2) test whether semaglutide treatment is effective for the management of significant fibrosis due to NAFLD in high-risk patients. Learn more.
General Screening Protocol for Affected and Unaffected Participants in Studies of Alcohol Use Disorder: The goal is to conduct a screening procedure to be used in evaluating individuals either with or without an alcohol use disorder (AUD) to determine whether it is safe and appropriate for them to participate in a clinical trial, imaging study, genetic study, or other research protocol that matches their interests and eligibility. Our goal is to enroll up to 500 people in each group or a total of 1000 people. Learn more.
Fox Insight: Fox Insight is an online clinical study where people with Parkinson’s disease and their loved ones share information that could transform the search for better treatments. Learn more.
š NEWS & NOTEWORTHY
āļø GLP-1 agonists – Patients discovering unanticipated health benefits!
š° In Antarctica, gold rains from the sky!
š§ First in-human clinical trial of the Brain Computer Interface. Whatās the progress?
š” Home as a Health Care Hub – FDA launches a new initiative.
šø The Starliner crew ready to fly, the spacecraft’s debut mission with humans on board.
š¤ TEAM UPDATES
š SOC 2 Compliance
At TrialX, we recognize the critical importance of trust in our services, and our SOC 2 compliance reaffirms our steadfast commitment to protecting the privacy and security of all stakeholders involved in clinical research. Maintaining compliance is critical and we are committed to renew our SOC 2 report annually. Learn more.
š Ramadan Delights!
The month of Ramadan is a journey of spiritual growth, self-discovery, and deep devotion. As the crescent moon graces the sky, Muslims around the globe embark on a beautiful adventure of fasting from dawn till dusk for twenty-nine to thirty days, which culminates in the joyous festival of Eid. And what makes this journey even more enchanting? The unexpected delight of surprise gifts, delivered right to our doorstep, as Ramadan draws to a close!
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions to streamline patient recruitment and remote data collection. Stay tuned for more updates as we continue to look up to the moon!
